$FEMY Income Statement | Understand Stock

$FEMY

$1.37 -$0.04 (2.84%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Sales
Cost of sales (excluding depreciation expense)
Gross margin
Operating expenses:
Research and development
Sales and marketing
General and administrative
Depreciation and amortization
Total operating expenses
Loss from operations
Other (expense) income:
Other income
Interest income
Change in fair value of conversion option liability
Change in fair value of warrants liabilities
Interest expense
Other expense
Total other expense, net
Loss before income taxes
Income tax expense
Net loss
Change in fair value of available for sale investments
Total comprehensive loss
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Net loss per share attributable to common stockholders, basic (in Dollars per share)
Net loss per share attributable to common stockholders, diluted (in Dollars per share)
Weighted-average common shares and pre-funded warrants outstanding- basic (in Shares)
Weighted-average common shares and pre-funded warrants outstanding- Diluted (in Shares)

Comments